Tango Therapeutics to Participate in the Jefferies London Healthcare Conference

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX) announced participation in the Jefferies London Healthcare Conference on November 18, 2021. The management team will present, with the session available on-demand starting at 8 AM GMT. A replay will be accessible for 30 days on the company's website. Tango focuses on precision cancer medicine, leveraging synthetic lethality to target cancer cells and enhance treatment efficacy. For more details, visit tangotx.com.

CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in the the Jefferies London Healthcare Conference. The presentation will be available on-demand starting at 8 AM GMT on Thursday, November 18, 2021.

A webcast of the event will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 30 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Investor Contact:
Sam Martin
Argot Partners
tango@argotpartners.com

Media Contact:
Joshua R. Mansbach
Argot Partners
tango@argotpartners.com

FAQ

What is the date of the Jefferies London Healthcare Conference for TNGX?

The Jefferies London Healthcare Conference for Tango Therapeutics is scheduled for November 18, 2021.

Where can I watch the TNGX presentation from the Jefferies conference?

The TNGX presentation will be available on-demand on the company's website under the 'Events & Presentations' tab.

How long will the TNGX conference presentation be available for replay?

The replay of the TNGX conference presentation will be archived for 30 days.

What is the focus of Tango Therapeutics (TNGX)?

Tango Therapeutics focuses on discovering novel drug targets for precision cancer medicine using synthetic lethality.

What key approach does TNGX utilize in its cancer research?

TNGX leverages the genetic principle of synthetic lethality to develop therapies targeting cancer cells.